Xentuzumab (Anti-IGF-1)

Xentuzumab (Anti-IGF-1) is a recombinant a humanized monoclonal antibody that targets IGF ligands IGF-1 and IGF-2. Xentuzumab inhibits both of IGF-1 and IGF-2 growth-promoting signalling and suppresses AKT activation. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2457
Sku # A2457-1mg*25
Pricing 1mg*25, $4170.00
Feedback